Publications by authors named "V Marchesi"
Seminoma is a highly curable disease; therefore, long-term morbidity of oncological treatment represents a crucial stake. In view of the considerable advances made in radiotherapy in the past decade, we aim to shed light on current and future strategies that hold promises for the management of stage II seminoma.
View Article and Find Full Text PDFReirradiation of bone metastasis: A narrative review of the literature.
Cancer Radiother
November 2024
Article Synopsis
- - Patients with bone metastasis often undergo palliative radiotherapy, with about 20% needing reirradiation to manage symptoms or control local progression of cancer lesions.
- - Around two-thirds of patients experience pain relief from bone reirradiation, but spinal cord damage presents a risk, particularly with cumulative doses over 50 Gy.
- - Effective reirradiation requires careful planning, a multidisciplinary team approach, assessing alternative treatment options, and ensuring that patients are monitored closely after the procedure.
Obtaining consent to care requires the radiation oncologist to provide loyal information and to ensure that the patient understands it. Proof of such an approach rests with the practitioner. The French Society for Radiation Oncology (SFRO) does not recommend the signature of a consent form by the patient but recommends that the radiation oncologist be able to provide all the elements demonstrating the reality of a complete information circuit.
View Article and Find Full Text PDFPurpose: Brachytherapy (BT) is a validated radiation technique for treatment of early stage tumors of oral cavity and oropharynx. This study aimed to analyze the results of our institute's patients after replacing low-dose-rate (LDR) with pulse-dose-rate (PDR) brachytherapy.
Material And Methods: We retrospectively collected data from all patients treated between 2009 and 2020 for squamous cell carcinoma (floor of the mouth, tongue, and oropharynx) using adjuvant interstitial BT with or without external RT.
Aim: The analyses here reported aim to compare the screening performance of digital tomosynthesis (DBT) versus mammography (DM).
Methods: MAITA is a consortium of four Italian trials, REtomo, Proteus, Impeto, and MAITA trial. The trials adopted a two-arm randomised design comparing DBT plus DM (REtomo and Proteus) or synthetic-2D (Impeto and MAITA trial) versus DM; multiple vendors were included.